Sonoma Pharmaceuticals grants 30,000 stock options each to CEO, CFO, COO and directors

Sonoma Pharmaceuticals, Inc.

Annual grant of stock options to employees, executive officers, and directors on January 14, 2022.
Exercise price set at $4.57 per share, based on closing price on grant date.
Options vest in three equal tranches at 6, 18, and 30 months; full vesting upon change of control.
CEO Amy Trombly, CFO Jerry Dvonch, and COO Bruce Thornton each received 30,000 options.
Each director also received 30,000 options.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.